Measurement of serum and urine C-peptide (CPR) have been used per-and hypothyroidism i n t h e developing r a t . Because o f i nto demonstrate residual insulin producing capacity in diabetes.
c r e a s i n g use o f t h y r o i d repiacement therapy i n t h e human neonate
The duration and dynamics of residual 0-cell function have not we s t
u d i e d t h e e f f e c t s o f abnormal t h y r o i d s t a t e s on rGH d u r i n g been thoroughly investigated. Sequential measurement of serum t h e neonatal p e r i o d .
L i t t e r s o f newborn r a t pups were i n j e c t e d d a i l y from ages 0-1 days w i t h t h y r o x i n e (T4), 0.4 wglgram o f body weight, w h i l e l i ttermate c o n t r o l s were i n j e c t e d d a i l y w i t h s a l i n e . Other l i t t e r s were rendered h y p o t h y r o i d by i n j e c t i o n o f t h e mothers w i t h 50 mg p r o p y l t h i o u r a c i l (PTU) d a i l y from 18 days g e s t a t i o n v i a i n t r ag a s t r i c gavage. C o n t r o l s r e c e i v e d an equal volume o f s a l i n e .
I n b o t h experimental groups, t h e developmental curve f o r rGH i n c o n t r o l s as measured by r a d i o i n u n o a s s a y f e l l from 120 n g~m l on day one t o 10 nglml on day 19. Both t h y r o x i n e and PTU t r e a t e pups showed a c o n s i s t e n t depression i n rGH l e v e l s a t each age o f e a r l y development. The maximum d e f i c i t i n T4 animals was 6% o f c o n t r o l a t day 18, and i n PTU animals, was 14% o f c o n t r o l a t day 15. I n d i v i d u a l data p o i n t s f o r t r e a t e d and c o n t r o l animals were l o g transformed, f o l l o w i n g which t h e developmental p r o f i l e s wpre analyzed by a one way a n a l y s i s o f covariance. Both hyper-and i y p o t h y r o i d pups showed a s t a t i s t i c a l l y s i g n i f i c a c t d e f i c i e n c y o rGH throughout e a r l y development. The e a r l y suppression i n b o t h z o n d i t i o n s suggests t h e n e c e s s i t y f o r c a r e f u l t i t r a t i o n o f t h y --o i d replacement therapy i n human c o n g e n i t a l hypothyroidism.
and urine CPR were made during and after therapy for ketoacidosis in a 15 year old boy with JODM of 10 months duration. Serum CPR ranged from 0.3-0.6 ng/ml, approaching the lowest levels detectable by RIA. Urine C-peptide excretion increased over the 5 days of observation.
C-pept ide C-peptide %reatinhe ng/mg creatinine ng/240 ml/min/l. --85 Urinary clearance and fractional excretion (CC-peptide of C-peptide also increased 6-10 fold.
lCcreat .)
Despite low serum CPR, these data are compatible with increased endogenous insulin production during therapy for ketoacidosis. Changes in renal blood flow or tubular disposition of C-peptide may have contributed to the progressive increase in urine C-peptide excretion. qd of T3, and serum TSH was < 12 W~/ml in all within weeks. However, among 5 of 6 infants treated with Tq alone, the TSH did not suppress below 12 WU/ml until )/ 3 months of therapy. During therapy in the 7 infants treated with T4 alone, serial reverse T (rT3) determinations revealed peak concentrations (1C + 13.8 ng?dl, mean + SEM) simultaneous with the initial suppression of TSH to normal and significantly greater than the rT3 levels just prior to suppression of TSH (66.7 + 15 ngldl, ~<.001 >y paired t test) and following TSH suppression (83.8 2 16 ng/dl <.05).
FFECTS OF THYROID HORMONE THERAPY IN CONGENITAL POTHYROIDISM (CH)
In summary, 1) Tq alone is adequate therapy for CH iden ified early by screening programs, but is associated with delay ed TSH suppression in infants diagnosed on the basis of clinic41 symptomatology alone. 2) The peak rT3 levels associated with the Lnitial TSH suppression suggest an increase in the monodeiodinaion of Tq to rT3, or decreased clearance of rTg which may indiate the development of intracellular euthyroidism. f and ~adiolo~y,( ~ittsbur~h, PA HHG in AIP has not been reported. A 20 yr. old male with AIP and inappropriate secretion of ADH was hyposmic, tall (178 cm), eunuchoid (U/L, 0.84). had a high-pitched voice, absent facial hair and Tanner 2-3 pubic hair. His testes were small (R, 8 ml; L, 10 ml). Karyotype was XY. Basal serum FSH, 5.5 mI~/ml; LH, 5.6 mIU/ml and T, 54 ngldl were all low and PRL was normal. Mea nocturnal LH (6.5 + 0.2 (SE) m~U/ml) was low and showed no perio dic pulses. Mean nocturnal T (156 + 13 ngldl) was also low, wit minimal fluctuations between 2200 h and 0300 h; however, between 0300 h and 0800 h two peaks of T occurred simultaneously with those of cortisol. The responses of LH to LHRH and TSH and PRL to TRH were normal. Nocturnal GH secretion was characterized by 3 peaks. Basal GH was normal and increased to 16 ng/ml during AITT and remained above 10 ng/ml between 60 and 150 minutes. Basal T, 252 ng/dl, increased to 2049 ng/dl after 4 days of im hCG (5000 unitsld). Basal 24 h urine P amino levulinic acid (ALA), 18 mg and porphobilinogen (PBG), 68 mg, respectively, were high and did not change after 4 days of hCG (ALA, 25 mgld; PBG, 51 mg/d). Three attacks of AIP occurred during 8 months prior to T therapy, but none occurred during 7 months of hCG or T therapy. Conclusions: 1) Hypothalamic dysfunction in AIP may cause HHG 2) hCG and T do not alter ALA and PBG excretion and nay Protect these patients from repeated attacks. There was no correlation between DOC and 18-OH-DOC levels and plasma renin activ ity, severity or type of hypertension. During a continuous 5-da ACTH infusion (40 U/24h) urinary 18-OH-WC increased 20-50 fold in all groups. Plasma DOC concentration and urinary T H W C excre tion increased 20 fold, and urinary free DOC rose 20-50 fold in the control group and in the children with essential hypertension. The highest increase of THDOC (50 fold) and free DOC (100 fold) after ACTH was seen in the children with dexamethasone-sup pressible hyperaldosteronism. However neither the observed salt retention nor the rise in blood pressure after ACTH stimulation #ere correlated with DOC or 18-OH-DOC in any of the groups. The rise in blood pressure after ACTH was independent of changes in salt and water balance. Conclusions: 1) DOC and 18-OH-DOC do no sppear to play a major role in most cases of juvenile hyperteniion.
1-DESOXYCORTICOSTERONE (DOC) AND 18-HYDFOXY-DOC
2) The marked rise of DOC and 18-OH-DOC may contribute to the rise in blood pressure with ACTH. 3) The blood pressure elevation after ACTH cannot be solely attributed to salt retention ,resultinq from an increase in DOC secretion. The testosterone (T) secretion of collagenase-dispersed rat interstitial cells exposed to gonadotropin provides a highly sensitive in vitro bioassay (RICT) for LH (Dufau al, JCEM 39: 610, 1974) . The serum levels of biologically active (B) LH and the relationship to imrnunoreactive (I) LH have been studied in 12 prepubertal (PRE) (age 2-17, T=9.D ngldl) and 12 pubertal (PUB) (age 10-16, T=164) normal males. Mean B-LH levels in PRE (<lmIU/ml, IRP-2-hMG) are significantly (p <.001) lower than in PUB (13.8t2.4 (~sE). B-LH was undetectable in all PRE and not separable by Tanner stages in PUB. I-LH levels, measured by double-antibody RIA, in PRE (3.6t1.0) are also lower (p < .Dl) than in PUB (9.321.5).
B/I ratios in PRE (<0.6) are lower than in PUB (2.120.7).
The BII ratio in PRE is lower than in normal adult males (2.5'0.1) and closer to the levels reported in normal premenopausal women (1.220.1).
The B/I ratio in PUB does not differ from that in adult males. In conclusion: (1) The RICT bioassay method for quantitating serum LH is applicable to studies in childhood; (2) RIA measurements of LH apparently overestimate true bioactive concentrations in subjects with minimal pituitary LH secretion; (3) The similarity of B/I ratio in PRE males to adult premenopausal women and in PUB to adult males suggests that sex steroids may modulate the biologic aualitv. as well as auantitv. of ~ituitarv LH secretion.
